Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Magna International Targets at Least 15% Annual Adjusted EPS Growth Through 2030

Magna International Targets at Least 15% Annual Adjusted EPS Growth Through 2030

MT newswireMT newswire2026/11/11 13:33
09:33 AM EST, 11/11/2026 (MT Newswires) -- Magna International (MGA) said Wednesday that it expects to target compound annual adjusted earnings per share growth of at least 15% through 2030. The company also targets annual organic sales growth of 2% to 4% above the market, at least 200 basis points of adjusted EBIT margin improvement by 2030 and average free cash flow conversion of 85% or more for 2027 to 2030. Magna targets adjusted return on invested capital above 15% by 2030, with existing business and awarded programs supporting more than 90% of expected 2028 sales and over 60% of 2030 sales, the company said. The company intends to repurchase nearly 26 million shares over the next 12 months under its renewed normal course issuer bid, it added. Magna International shares were up more than 1% in recent Wednesday premarket activity.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency

The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.

智通财经•2026/11/12 02:26

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07